Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:08:15 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



C:PHRM - PharmaTher Holdings Ltd. - http://www.pharmather.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHRM - C  3.00.215·0.254.00.24-0.005-2.096.421640.25  0.255  0.2150.43  0.0815:59:59Apr 2315 min RT 2¢
CSE - C3.00.215·0.254.00.24-0.005-2.062.513400.25  0.255  0.2150.43  0.0815:59:5915 min
NEO ATS - U 0.2456.5180.255  0.255  0.23515:57:5515 min
Omega - O 0.2459.0230.255  0.255  0.24515:57:5515 min
Chi-X - X 0.24-0.005-2.00.5010.24  0.24  0.2411:53:5715 min
CX2 - H 0.24517.0460.25  0.25  0.23515:57:5515 min
CXD - D 0.2450.53    Apr 1015 min
TriAct - M 0.2450.43    15 min

Recent Trades - Last 10 of 64
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59C0.24-0.00550079 CIBC79 CIBCK
15:57:55H0.245 10,00079 CIBC1 AnonymousK
15:57:55O0.245 7,0001 Anonymous1 AnonymousK
15:57:55U0.245 1,00079 CIBC2 RBCK
15:57:55U0.245 50079 CIBC2 RBCK
15:57:55U0.245 50079 CIBC2 RBCK
15:57:55U0.245 50079 CIBC2 RBCK
15:57:55U0.245 2,00079 CIBC2 RBCK
15:57:55C0.245 5,00079 CIBC9 BMO NesbittK
15:57:55C0.245 50079 CIBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-23 02:12C:PHRM0.215SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-23 02:11C:PHRM0.215SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-18 16:10C:PHRM0.23News ReleasePharmather receives complete response for ketamine ANDA
2024-04-16 14:03C:PHRM0.21News ReleasePharmather hopes to submit ketamine responses this week
2024-04-02 11:21C:PHRM0.385News ReleaseRevive clinical study enrolls nearly 50% of sample
2024-02-21 13:19C:PHRM0.21News ReleasePharmather, Pharmadrug begin Sairiyo plan for PD-001
2024-02-14 13:15C:PHRM0.225News ReleasePharmadrug unit to manufacture PD-001 for human studies
2024-02-12 11:12C:PHRM0.19News ReleasePharmather talks ketamine ANDA, possible deficiencies
2024-01-10 11:21C:PHRM0.225News ReleasePharmather expects FDA ketamine approval April 29, 2024
2023-10-30 19:15C:PHRM0.135SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-30 19:15C:PHRM0.135SEDAR Interim MD & ASEDAR Interim MD & A
2023-09-28 18:20C:PHRM0.14SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-09-27 10:36C:PHRM0.15News ReleasePharmather's Ketarx drug application accepted by FDA
2023-09-06 10:38C:PHRM0.14News ReleasePharmather submits new drug application for Ketarx
2023-07-18 10:06C:PHRMNews ReleasePharmather completes PharmaPatch research study
2023-06-27 12:05C:PHRM0.15News ReleasePharmather files presubmission facility correspondence
2023-06-20 07:51C:PHRM0.105News ReleasePharmather, Vitruvias to collaborate for Ketarx
2023-06-12 09:36C:PHRM0.095News ReleasePharmather hopes to receive Ketarx FDA OK in Q1 2024
2023-05-02 10:02C:PHRM0.12News ReleasePharmather submits Ketarx fast-track application to FDA
2023-04-28 18:30C:PHRM0.125SEDAR MD & ASEDAR MD & A